Acquiring Company
Merck
Acquired Company
Cidara Therapeutics
RahwaySan DiegoManufacturingBiotechnologyHealthcareHealth CareBiotechnologyDescription
On November 14, Merck & Co. Inc. announced its acquisition of Cidara Therapeutics Inc. in an all-cash deal valued at $9.2 billion, offering $221.5 per share. This acquisition aims to enhance Merck's infectious disease portfolio, particularly with Cidara's lead drug candidate, CD388. The deal is expected to close in the first quarter of 2026, pending required approvals.
Quick answer
Merck is acquiring Cidara Therapeutics for $9.2 billion, announced November 23, 2025. Merck is based in Rahway, New Jersey, United States.
- How much did Merck pay for Cidara Therapeutics?
- The reported deal value is $9.2 billion.
- What does Merck do?
- For over 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our..
- Where are Merck and Cidara Therapeutics based?
- Merck is based in Rahway, New Jersey, United States. Cidara Therapeutics is based in San Diego, California, United States.
- Who are the decision-makers at Merck?
- Fundz holds 3 contacts at Merck. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Manufacturing
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- ClearPoint Neuro acquires IRRAS for $5 million, $5M (November 20, 2025)
- Harrow acquires Melt Pharmaceuticals for sedation solutions (November 18, 2025)
- Galecto, Inc. Acquires Damora Therapeutics, Inc. (November 10, 2025)
- AbbVie acquires Bretisilocin for mental health expansion (October 15, 2025)
- Merck to acquire Cidara Therapeutics soon (November 14, 2025)
- Merck Sharp & Dohme LLC to Acquire Cidara Therapeutics, Inc. (November 13, 2025)
Who to call at Merck, and when
When Merck changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Merck raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Merck, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Merck. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Merck makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Cidara Therapeutics?
Cidara Therapeutics was acquired by Merck, based in Rahway. The deal was reported on November 23, 2025. Merck is publicly traded (MRK) and operates in Manufacturing.
When did Merck acquire Cidara Therapeutics?
Merck's acquisition of Cidara Therapeutics was reported on November 23, 2025. On November 14, Merck & Co. Inc. announced its acquisition of Cidara Therapeutics Inc. in an all-cash deal valued at $9.2 billion, offering $221.5 per share. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Cidara Therapeutics do?
Cidara Therapeutics is using its proprietary Cloudbreak® platform to develop novel DFCs comprising targeted small molecules or peptides coupled to a proprietary human antibody fragment. It is privately held, operating in Biotechnology, and is based in San Diego.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.